Amneal Pharmaceuticals, Class Stock Return On Asset
| AMRX Stock | USD 8.38 0.01 0.12% |
Amneal Pharmaceuticals, Class fundamentals help investors to digest information that contributes to Amneal Pharmaceuticals,'s financial success or failures. It also enables traders to predict the movement of Amneal Stock. The fundamental analysis module provides a way to measure Amneal Pharmaceuticals,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amneal Pharmaceuticals, stock.
Return On Assets is likely to rise to -0.02 in 2024. Amneal | Return On Asset |
Amneal Pharmaceuticals, Class Company Return On Asset Analysis
Amneal Pharmaceuticals,'s Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Amneal Pharmaceuticals, Return On Asset | 0.0594 |
Most of Amneal Pharmaceuticals,'s fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amneal Pharmaceuticals, Class is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Amneal Return On Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Amneal Pharmaceuticals, is extremely important. It helps to project a fair market value of Amneal Stock properly, considering its historical fundamentals such as Return On Asset. Since Amneal Pharmaceuticals,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Amneal Pharmaceuticals,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Amneal Pharmaceuticals,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Amneal Total Assets
Total Assets |
|
Based on the latest financial disclosure, Amneal Pharmaceuticals, Class has a Return On Asset of 0.0594. This is 100.68% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The return on asset for all United States stocks is 142.43% lower than that of the firm.
Amneal Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amneal Pharmaceuticals,'s direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amneal Pharmaceuticals, could also be used in its relative valuation, which is a method of valuing Amneal Pharmaceuticals, by comparing valuation metrics of similar companies.Amneal Pharmaceuticals, is currently under evaluation in return on asset category among its peers.
Amneal Pharmaceuticals, ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Amneal Pharmaceuticals,'s sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Amneal Pharmaceuticals,'s managers, analysts, and investors.Environmental | Governance | Social |
Amneal Fundamentals
| Return On Equity | -1.86 | ||||
| Return On Asset | 0.0594 | ||||
| Profit Margin | (0.07) % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 5.17 B | ||||
| Shares Outstanding | 309.84 M | ||||
| Shares Owned By Insiders | 53.34 % | ||||
| Shares Owned By Institutions | 46.26 % | ||||
| Number Of Shares Shorted | 3.5 M | ||||
| Price To Earning | 230.50 X | ||||
| Price To Book | 86.10 X | ||||
| Price To Sales | 1.45 X | ||||
| Revenue | 2.39 B | ||||
| Gross Profit | 791.46 M | ||||
| EBITDA | 500.78 M | ||||
| Net Income | (48.72 M) | ||||
| Cash And Equivalents | 87.33 M | ||||
| Cash Per Share | 0.58 X | ||||
| Total Debt | 2.75 B | ||||
| Current Ratio | 1.74 X | ||||
| Book Value Per Share | (0.30) X | ||||
| Cash Flow From Operations | 345.58 M | ||||
| Short Ratio | 4.23 X | ||||
| Earnings Per Share | (0.86) X | ||||
| Price To Earnings To Growth | (0.30) X | ||||
| Target Price | 10.5 | ||||
| Number Of Employees | 7.85 K | ||||
| Beta | 1.18 | ||||
| Market Capitalization | 3.88 B | ||||
| Total Asset | 3.47 B | ||||
| Retained Earnings | (490.18 M) | ||||
| Working Capital | 531.27 M | ||||
| Current Asset | 753.39 M | ||||
| Current Liabilities | 310.2 M | ||||
| Net Asset | 3.47 B |
About Amneal Pharmaceuticals, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amneal Pharmaceuticals, Class's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amneal Pharmaceuticals, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amneal Pharmaceuticals, Class based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Amneal Stock Analysis
When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.